In a study, patients with high-risk nonmuscle invasive bladder cancer receiving bacillus Calmette-Guérin intravesical therapy rather than upfront cystectomy had improved cancer-specific survival by 10 percentage points.
Vibegron does not inhibit the CYP2D6 pathway, and thereby avoids drug-drug interactions, according to an EMPOWUR investigator.
US women in all age groups are affected by urinary incontinence of one type or another, according to new research.
Each 1 mL/min/1.73 m2 decline in estimated glomerular filtration rate was associated with a 3.7% increased risk of stone development in the following 2 years in adjusted analyses, a study found.
Among patients who undergo treatment for T1a renal cell carcinoma, 5- and 10-year cancer-specific mortality rates rise with age across treatment modalities, a study found.
Obese men with metastatic castration-resistant prostate cancer have superior cancer-specific and overall survival than their overweight and normal-weight counterparts, a study found.
Active surveillance for small renal masses in older patients offers long-term oncologic efficacy similar to that of partial or radical nephrectomy.
Greater muscle mass independently predicts longer survival in men with metastatic or castration-resistant prostate cancer, a study found.
Separate studies demonstrated that partial nephrectomy could be an acceptable alternative to radical nephrectomy in selected cases of high-risk kidney cancer and large renal masses.
Patients who received intravesical BCG instillation following surgery for nonmuscle-invasive bladder cancer had a lower risk of recurrence of upper tract urothelial carcinoma and bladder cancer, a study found.
